CH611292A5 - - Google Patents

Info

Publication number
CH611292A5
CH611292A5 CH494875A CH494875A CH611292A5 CH 611292 A5 CH611292 A5 CH 611292A5 CH 494875 A CH494875 A CH 494875A CH 494875 A CH494875 A CH 494875A CH 611292 A5 CH611292 A5 CH 611292A5
Authority
CH
Switzerland
Application number
CH494875A
Inventor
Paul Edward Aldrich
Gilbert Harvey Berezin
Bruce Ivor Dittmar
Original Assignee
Du Pont
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Du Pont filed Critical Du Pont
Publication of CH611292A5 publication Critical patent/CH611292A5/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D331/00—Heterocyclic compounds containing rings of less than five members, having one sulfur atom as the only ring hetero atom
    • C07D331/04—Four-membered rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/46—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings substituted on the ring sulfur atom
    • C07D333/48—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings substituted on the ring sulfur atom by oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
CH494875A 1974-04-17 1975-04-17 CH611292A5 (cs)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US46169974A 1974-04-17 1974-04-17
US05/555,307 US4009847A (en) 1974-04-17 1975-03-11 1-Tertiary-alkyl-3-(substituted thienyl)ureas and 1-tertiary-alkyl-3-(substituted thietyl)ureas as antihypertensive agents

Publications (1)

Publication Number Publication Date
CH611292A5 true CH611292A5 (cs) 1979-05-31

Family

ID=27040095

Family Applications (1)

Application Number Title Priority Date Filing Date
CH494875A CH611292A5 (cs) 1974-04-17 1975-04-17

Country Status (21)

Country Link
US (1) US4009847A (cs)
JP (1) JPS50148349A (cs)
AR (1) AR208545A1 (cs)
CA (1) CA1047042A (cs)
CH (1) CH611292A5 (cs)
DD (1) DD117223A5 (cs)
DE (1) DE2516554A1 (cs)
DK (1) DK164175A (cs)
ES (1) ES436648A1 (cs)
FI (1) FI751128A7 (cs)
FR (1) FR2267773B1 (cs)
GB (1) GB1461209A (cs)
HU (1) HU173052B (cs)
IE (1) IE41143B1 (cs)
IL (1) IL47095A (cs)
LU (1) LU72306A1 (cs)
NL (1) NL7504570A (cs)
NO (1) NO144071C (cs)
PH (1) PH11722A (cs)
SE (1) SE417965B (cs)
YU (1) YU96075A (cs)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4156738A (en) * 1977-10-07 1979-05-29 E. I. Du Pont De Nemours And Company Ureidonitriles useful as antihypertensives
US6187799B1 (en) * 1997-05-23 2001-02-13 Onyx Pharmaceuticals Inhibition of raf kinase activity using aryl ureas
US6344476B1 (en) * 1997-05-23 2002-02-05 Bayer Corporation Inhibition of p38 kinase activity by aryl ureas
US7329670B1 (en) * 1997-12-22 2008-02-12 Bayer Pharmaceuticals Corporation Inhibition of RAF kinase using aryl and heteroaryl substituted heterocyclic ureas
US20080300281A1 (en) * 1997-12-22 2008-12-04 Jacques Dumas Inhibition of p38 Kinase Activity Using Aryl and Heteroaryl Substituted Heterocyclic Ureas
US7517880B2 (en) * 1997-12-22 2009-04-14 Bayer Pharmaceuticals Corporation Inhibition of p38 kinase using symmetrical and unsymmetrical diphenyl ureas
US20080269265A1 (en) * 1998-12-22 2008-10-30 Scott Miller Inhibition Of Raf Kinase Using Symmetrical And Unsymmetrical Substituted Diphenyl Ureas
US7928239B2 (en) 1999-01-13 2011-04-19 Bayer Healthcare Llc Inhibition of RAF kinase using quinolyl, isoquinolyl or pyridyl ureas
IL144144A0 (en) * 1999-01-13 2002-05-23 Bayer Ag Omega-carboxy aryl substituted diphenyl ureas as p38 kinase inhibitors
WO2000042012A1 (en) 1999-01-13 2000-07-20 Bayer Corporation φ-CARBOXYARYL SUBSTITUTED DIPHENYL UREAS AS RAF KINASE INHIBITORS
US8124630B2 (en) * 1999-01-13 2012-02-28 Bayer Healthcare Llc ω-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
ME00275B (me) * 1999-01-13 2011-02-10 Bayer Corp ω-KARBOKSIARIL SUPSTITUISANI DIFENIL KARBAMIDI KAO INHIBITORI RAF KINAZE
US7235576B1 (en) 2001-01-12 2007-06-26 Bayer Pharmaceuticals Corporation Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
US7371763B2 (en) * 2001-04-20 2008-05-13 Bayer Pharmaceuticals Corporation Inhibition of raf kinase using quinolyl, isoquinolyl or pyridyl ureas
CA2468463C (en) * 2001-12-03 2013-06-18 Bayer Pharmaceuticals Corporation Aryl urea compounds in combination with other cytostatic or cytotoxic agents for treating human cancers
US20080108672A1 (en) * 2002-01-11 2008-05-08 Bernd Riedl Omega-Carboxyaryl Substituted Diphenyl Ureas As Raf Kinase Inhibitors
WO2003068229A1 (en) * 2002-02-11 2003-08-21 Bayer Pharmaceuticals Corporation Pyridine, quinoline, and isoquinoline n-oxides as kinase inhibitors
WO2003068223A1 (en) * 2002-02-11 2003-08-21 Bayer Corporation Aryl ureas with raf kinase and angiogenesis inhibiting activity
ATE529406T1 (de) * 2002-02-11 2011-11-15 Bayer Healthcare Llc Aryl-harnstoffe als kinase inhibitoren
EP1478358B1 (en) * 2002-02-11 2013-07-03 Bayer HealthCare LLC Sorafenib tosylate for the treatment of diseases characterized by abnormal angiogenesis
US7557129B2 (en) * 2003-02-28 2009-07-07 Bayer Healthcare Llc Cyanopyridine derivatives useful in the treatment of cancer and other disorders
US8796250B2 (en) * 2003-05-20 2014-08-05 Bayer Healthcare Llc Diaryl ureas for diseases mediated by PDGFR
DE602004010407T2 (de) * 2003-07-23 2008-10-16 Bayer Pharmaceuticals Corp., West Haven Fluorsubstituierter omega-carboxyaryldiphenylharnstoff zur behandlung und prävention von krankheiten und leiden
JP2007535565A (ja) * 2004-04-30 2007-12-06 バイエル ファーマシューティカルス コーポレーション 癌の治療に有用な置換ピラゾリル尿素誘導体

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH452475A (de) * 1965-05-20 1968-05-31 Bayer Ag Verfahren zum Färben und Bedrucken von synthetischem Textilmaterial mit Anthrachinonfarbstoffen

Also Published As

Publication number Publication date
ES436648A1 (es) 1977-08-01
IE41143L (en) 1975-10-17
NO144071C (no) 1981-06-17
NL7504570A (nl) 1975-10-21
SE417965B (sv) 1981-04-27
SE7503523L (sv) 1975-10-20
DE2516554A1 (de) 1975-10-30
DK164175A (da) 1975-10-18
US4009847A (en) 1977-03-01
NO144071B (no) 1981-03-09
FI751128A7 (cs) 1975-10-18
AU8013575A (en) 1976-10-21
JPS50148349A (cs) 1975-11-27
IE41143B1 (en) 1979-10-24
FR2267773A1 (cs) 1975-11-14
DD117223A5 (cs) 1976-01-05
IL47095A0 (en) 1975-06-25
PH11722A (en) 1978-05-30
YU96075A (en) 1983-04-27
AR208545A1 (es) 1977-02-15
IL47095A (en) 1978-03-10
LU72306A1 (cs) 1976-03-17
NO751351L (cs) 1975-10-20
CA1047042A (en) 1979-01-23
FR2267773B1 (cs) 1978-08-18
HU173052B (hu) 1979-02-28
GB1461209A (en) 1977-01-13

Similar Documents

Publication Publication Date Title
NO751351L (cs)
AU7459474A (cs)
AU495930B2 (cs)
AU485022B2 (cs)
AU7465674A (cs)
AR198999Q (cs)
AU480371A (cs)
BE827400A (cs)
AU480069A (cs)
AU480264A (cs)
AU480308A (cs)
AU479969A (cs)
AU480902A (cs)
AU480925A (cs)
AU481220A (cs)
AU481597A (cs)
AU481798A (cs)
AU481898A (cs)
AU481934A (cs)
AU479765A (cs)
AU482307A (cs)
AU479523A (cs)
AU490706A (cs)
AU479448A (cs)
AU479447A (cs)

Legal Events

Date Code Title Description
PL Patent ceased
PL Patent ceased